¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãá°èÇмú´ëȸ : 2024-04-26

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãá°èÇмú´ëȸ : 2024-04-26
±³À°ÀÏÀÚ : 2024-04-26
±³À°Àå¼Ò : ¼Ò³ëº§ Á¦ÁÖ ´ÙÀ̾ƸóµåȦ

±³À°ÁÖÁ¦ : 2024 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãá°èÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ
´ã´çÀÚ : ¹Ú¼Ò¹Î
¿¬¶ôó : 02-4883-5055  

À̸ÞÀÏ : office@kscpt.org

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ¸¶ÃëÅëÁõÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ¿¹¹æÀÇÇÐ, ¾à¸®ÇÐ

Âü¼®¿¹»óÀÎ : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : Á¦ÁÖƯº°ÀÚÄ¡µµ
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 180,000¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 09:00~10:00 Optimizing treatment for pediatric acute leukemia and development of CAR-T °­ÇüÁø(¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 10:30~11:00 ±Û·Î¹ú Á¦¾à.¹ÙÀÌ¿À ½Å¾à°³¹ß µ¿Çâ-¼¼Æ÷ À¯ÀüÂ÷ Ä¡·áÁ¦¸¦ Áß½ÉÀ¸·Î ¹ÚÈ¿Áø(±¹°¡½Å¾à°³¹ß»ç¾÷´Ü)

±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 11:00~11:30 CAR-T Ä¡·áÁ¦ÀÇ ±Û·Î¹ú °³¹ßµ¿Çâ ¹× Àü·« ±è°Ç¼ö(Å¥·Î¼¿)

±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 11:30~12:00 Genetically Engineered Mesenchymal Stem Cells for the Therapy of Glioblastoma ¼­ÇØ¿µ(¾ÆÁÖ´ëÇб³)

±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 13:30~14:00 ¼¼Æ÷À¯ÀüÀÚ Ä¡·áÁ¦ ºñÀÓ»ó °³¹ß ¹× °í·Á»çÇ× °­¼®¸ð(ÁÖ¹ÙÀÌ¿ÀÅ彺ÅØ)

±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 14:00~14:30 ¼¼Æ÷Ä¡·áÁ¦ÀÇ È¿´É ºÐ¼®¹ý: FACS¿Í ´ÜÀϼ¼Æ÷Àü»çü ºÐ¼® °æÇèÀ» Áß½ÉÀ¸·Î ±èÇöÁ¦(¼­¿ï´ëÇб³)

±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 14:30~15:00 Strategies for Cell Therapy Development: Optimizing Dosage ±èº´¿í(¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 15:30~15:50 Support for Clinical Research of Regenerative Medicine Advanced Therapy in Korea MinYoung Kim(Regenerative Medicine Acceleration Foundation)

±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 15:50~16:10 Challenges in the practical application of cell-processed products derived from iPS/ES cells Satoshi Yasuda(National Institute of Health Sciences)

±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 16:10~16:30 Recent Advances in CAR-T Cell Therapy in Hematologic Malignancies Nahoko Hosono(University of Fukui)

±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 16:50~17:10 Clinical trial protocol for porcine islet xenotransplantation in South Korea Byung-Joon Kim(Gil International Healthcare Center)

±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 17:10~17:30 Bioanalysis of recombinant viral vector by qPCR and digital PCR for biodistribution Yoichi Tanaka(National Institute of Health Sciences)

±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 17:30~17:50 PKPD modeling of cancer immunotherapy targeting IL-2 receptor Dongwoo Chae(Yonsei University College of Medicine)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãá°èÇмú´ëȸ : 2024-04-26""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2024 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2024) (2ÀÏÂ÷) : 2024-04-26
´ÙÀ½±Û ´ëÇÑ°£ÇÐȸ ÀüºÏÁöȸ Á¦28Â÷ ¿¬¼ö±³À° : 2024-04-26
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
375 ¼­¿ï 2018³â Á¦31ȸ ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ Á¤±âÇмú´ëȸ ¹× ÃÑȸ : 2018-08-25 0 632 2018-08-15
374 ÀÎõ ´ëÇѽ½°üÀýÇÐȸ Á¦5ȸ Korea-Japan Knee Osteotomy Symposium : 2018-08-25 0 1,342 2018-08-15
373 °­¿ø 2018³â ´ëÇѹÙÀÌ·¯½ºÇÐȸ ¿¬±¸È¸¿¬ÇÕ Á¤±âÇмú´ëȸ : 2018-08-24 0 343 2018-08-15
372 ¼­¿ï ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Ư°­ : 2018-08-23 0 303 2018-08-15
371 Àü³² ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ È£³²Áöȸ 283Â÷ ¿ù·ÊÁý´ãȸ : 2018-08-23 0 637 2018-08-15
370 ¼­¿ï ´ëÇÑ°³¿øÀÇÇùÀÇȸ Á¦4ȸ µÎ°æºÎ ÃÊÀ½ÆÄ ¿¬¼ö ¼¼¹Ì³ª : 2018-09-30 0 1,953 2018-08-08
369 ´ë±¸ ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ´ë±¸¡¤°æºÏ ÁöºÎȸ Á¦2Â÷ ÇмúÁý´ãȸ : 2018-09-20 0 537 2018-08-08
368 °æ³² ´ëÇѼҾưúÇÐȸ °³Á¤µÈ °¡¿Í»çÅ°º´ Áø·áÁöħ¿Ü 1°Ç : 2018-09-20 0 778 2018-08-08
367 °­¿ø ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ °­¿øÁöȸ Áý´ãȸ : 2018-09-15 0 1,162 2018-08-08
366 °æ±â ±¹¸³¾Ï¼¾ÅÍ ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ǹ®´õ½Ê°úÁ¤ : 2018-09-15 0 576 2018-08-08
365 Àü³² Çѱ¹°£´ãÃé¿Ü°úÇÐȸ Á¦13Â÷ ±¹Á¦½Ì±ÛÅäÇȽÉÆ÷Áö¿ò : 2018-09-14 0 1,044 2018-08-08
364 ºÎ»ê ºÎ»ê¼Ò¾Æ°úÇÐȸ Á¤±â Çмú Áý´äȸ : 2018-09-13 0 1,475 2018-08-08
363 ´ë±¸ ´ëÇÑÄ¡¸ÅÇÐȸ ´ë±¸°æºÏÁöȸ 2018 Ãß°è ½ÉÆ÷Áö¿ò : 2018-09-13 0 458 2018-08-08
362 ÀüºÏ Á¦6ȸ ÀüºÏ´ëÇб³º´¿ø Áö¿ªÀǾàÇ°¾ÈÀü¼¾ÅÍ ½ÉÆ÷Áö¾ö : 2018-09-11 0 361 2018-08-08
361 ¼­¿ï ´ëÇѼҾư¨¿°ÇÐȸ Á¦17ȸ ¿¬¼ö°­Á : 2018-09-09 0 438 2018-08-08
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷